高级检索
    王李杰. FLAURA2研究：EGFR突变阳性晚期NSCLC一线治疗模式新探索[J]. 循证医学, 2024, 24(3): 145-149. DOI: 10.12019/j.issn.1671-5144.202404040
    引用本文: 王李杰. FLAURA2研究：EGFR突变阳性晚期NSCLC一线治疗模式新探索[J]. 循证医学, 2024, 24(3): 145-149. DOI: 10.12019/j.issn.1671-5144.202404040
    shu
    WANG Li-jie. FLAURA2 Study: Mode Exploration of First-Line Treatment for Advanced NSCLC With EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2024, 24(3): 145-149. DOI: 10.12019/j.issn.1671-5144.202404040
    Citation: WANG Li-jie. FLAURA2 Study: Mode Exploration of First-Line Treatment for Advanced NSCLC With EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2024, 24(3): 145-149. DOI: 10.12019/j.issn.1671-5144.202404040
    shu

    FLAURA2研究：EGFR突变阳性晚期NSCLC一线治疗模式新探索

    FLAURA2 Study: Mode Exploration of First-Line Treatment for Advanced NSCLC With EGFR Mutation

      摘要
      • HTML全文
      • 参考文献(26)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回